JNJ1661010

JNJ-1661010 (Takeda-25) a potent and selective fatty acid amide hydrolase (FAAH) inhibitor with IC50s of 34 and 33 nM for rat FAAH and human FAAH, respectively. JNJ-1661010 can cross the blood-brain barrier and used as broad-spectrum analgesics.


Cat. No.: EX-A2218	Purity: >98%

	Chemical structure of JNJ1661010

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock	Quantity	Order
500mg	1385	In-stock
1g	2085	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	Takeda-25
CAS No.	681136-29-8
Purity	>98%
Formula	C19H19N5OS
Mol Weight	365.452
State	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Keith JM, et al. Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase. Bioorg Med Chem Lett. 2008 Sep 1;18(17):4838-43. [2]. Karbarz MJ, et al. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylicacid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase. Anesth Analg. 2009 Jan;108(1):316-29.
CoA	CoA of JNJ1661010

Smiles:	O=C(NC1=CC=CC=C1)N1CCN(CC1)C1=NC(=NS1)C1=CC=CC=C1


		Search